Skip to main content
    I

    Immuron Ltd ADR (IMRN)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.90
    +0.02 (+2.78%)

    Market Cap: $7.06M

    Last updated: Nov 17, 2026 at 11:04 AM ET

    Immuron Ltd ADR (IMRN) Financials: Revenue, Profit and Cash Flow

    Updated Aug 27, 2026. Financial statements from company filings, amounts in AUD.

    Immuron Ltd ADR reported revenue of AUD 7.55M for the fiscal year ended Jun 30, 2026, up 3.5% from the year before. That year, net income was AUD -3.75M with a net margin of -49.8%, operating cash flow was AUD -3.00M and free cash flow was AUD -3.00M. The quarter ended Jun 30, 2026 had revenue of AUD 3.58M and net income of AUD -1.95M.

    Revenue and Margins

    The operating margin was -61.4% in the fiscal year ended Jun 2026. Over the 9 years to Jun 2026, revenue grew from AUD 1.40M, a compound annual rate of 20.6%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Jun 20267.55M+3.5%64.5%-61.4%-49.8%
    Jun 20257.29M+48.6%65.4%-73.3%-71.6%
    Jun 20244.90M+171.7%68.1%-118.3%-141.5%
    Jun 20231.80M+135.8%96.4%-197.8%-209.8%
    Jun 2022765.19K+424.9%68.4%-375.0%-373.0%
    Jun 2021145.78K-94.2%-456.2%-5748.5%-5751.6%
    Jun 20202.52M+5.5%72.6%-115.8%-115.3%
    Jun 20192.39M+29.5%71.5%-195.0%-195.0%
    Jun 20181.84M+32.0%68.4%-162.1%-163.4%
    Jun 20171.40MN/A66.0%-600.9%-487.3%
    Annual, fiscal years ended Jun 2017 to Jun 2026

    Income Statement

    In the fiscal year ended Jun 2026, the net loss narrowed from the year before. In the quarter ended Jun 2026, the net loss narrowed from the same quarter a year earlier.

    Annual

    Line itemJun 2026Jun 2025Jun 2024Jun 2023Jun 2022Jun 2021Jun 2020Jun 2019Jun 2018Jun 2017
    Revenue7.55M7.29M4.90M1.80M765.19K145.78K2.52M2.39M1.84M1.40M
    Cost of revenue2.68M2.52M1.57M64.63K241.69K810.84K688.84K680.76K582.29K474.04K
    Gross profit4.87M4.77M3.34M1.74M523.50K-665.06K1.83M1.71M1.26M922.16K
    Research and development1.93M3.60M5.38M2.59M657.72K1.37M1.18M1.04M2.26M4.63M
    Operating income-4.63M-5.34M-5.80M-3.57M-2.87M-8.38M-2.92M-4.66M-2.99M-8.39M
    Net income-3.75M-5.22M-6.94M-3.79M-2.85M-8.38M-2.90M-4.66M-3.01M-6.80M
    EBITDA-4.63M-5.31M-5.17M-3.36MN/A-7.92M-2.87MN/AN/A-8.39M
    Fiscal years ended Jun 2017 to Jun 2026

    Quarterly

    Line itemJun 2026Dec 2025Jun 2025Mar 2025Dec 2024Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Dec 2023Sep 2023
    Revenue3.58M4.11M3.29M1.65M3.99M3.99M2.00M2.55M1.27M2.36M2.36M1.18M
    Gross profit2.35M2.60M2.11M1.05M2.66M2.66M1.33M1.76M878.23K1.58M1.58M790.17K
    Operating income-2.46M-2.26M-2.84M-1.40M-2.54M-2.54M-1.27M-3.78M-1.89M-2.02M-2.02M-1.01M
    Net income-1.95M-1.88M-2.76M-1.36M-2.49M-2.49M-1.24M-4.86M-2.43M-2.07M-2.07M-1.04M
    Last 12 quarters

    Balance Sheet

    As of Jun 2026, cash and equivalents of AUD 9.02M were 69.4% of total assets of 12.99M, against total liabilities of 1.99M.

    Annual

    Line itemJun 2026Jun 2025Jun 2024Jun 2023Jun 2022Jun 2021Jun 2020Jun 2019Jun 2018Jun 2017
    Total assets12.99M10.09M15.55M21.99M24.86M27.05M6.20M8.56M9.24M8.29M
    Current assets12.80M9.98M14.73M20.41M23.67M25.75M4.41M6.68M7.05M8.27M
    Cash and equivalents9.02M2.83M11.66M17.16M22.11M25.05M3.25M5.12M4.73M3.99M
    Total liabilities1.99M2.06M2.84M2.37M1.68M1.16M558.25K1.21M803.34K1.71M
    Short-term debtN/A45.27K40.56K38.77K34.38K20.50K42.18K00365.86K
    Shareholder equity11.01M8.03M12.71M19.62M23.18M25.90M5.64M7.35M8.44M6.57M
    Fiscal years ended Jun 2017 to Jun 2026

    Quarterly

    Line itemJun 2026Dec 2025Jun 2025Mar 2025Dec 2024Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Dec 2023Sep 2023
    Total assets12.99M15.12M10.09M10.13M12.17M12.17M12.17M15.55M15.55M19.88M19.88M19.88M
    Total liabilities1.99M2.06M2.06M2.06M1.83M1.83M1.83M2.84M2.84M2.36M2.36M2.36M
    Cash and equivalents9.02M9.99M2.83M2.83M7.74M7.74M7.74M11.66M11.66M15.21M15.21M15.21M
    Shareholder equity11.01M13.06M8.03M8.07M10.34M10.34M10.34M12.71M12.71M17.53M17.53M17.53M
    Last 12 quarters

    Cash Flow

    Operating cash flow was negative in the fiscal year ended Jun 2026.

    Annual

    Line itemJun 2026Jun 2025Jun 2024Jun 2023Jun 2022Jun 2021Jun 2020Jun 2019Jun 2018Jun 2017
    Operating cash flow-3.00M-6.14M-5.88M-2.49M-3.13M-3.05M-3.16M-1.29M-3.50M-7.03M
    Capital expenditures4.65K21957.74K10.05KN/A864N/A6.59K5.70K
    Free cash flow-3.00M-6.14M-5.88M-2.50M-3.14MN/A-3.17MN/A-3.51M-7.04M
    Investing cash flow2.97M-2.90M327.56K-2.74M11.74KN/A-864N/A-5.32K-5.70K
    Financing cash flow6.35M199.75K829-35.02K-36.26K19.76M1.17M1.48M4.35M8.70M
    Fiscal years ended Jun 2017 to Jun 2026

    Quarterly

    Line itemJun 2026Dec 2025Jun 2025Mar 2025Dec 2024Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Dec 2023Sep 2023
    Operating cash flow-767.06KN/A-2.14M-1.07M-3.99M-3.99M-2.00M-1.94M-1.94M-1.00M-1.00M-1.00M
    Capital expendituresN/A4.67K20111959898110
    Free cash flowN/AN/A-2.14M-1.07M-3.99M-3.99M-2.00M-1.94M-1.94M-1.00M-1.00M-1.00M
    Last 12 quarters

    Frequently Asked Questions About IMRN

    What is Immuron Ltd ADR's annual revenue?

    Immuron Ltd ADR reported revenue of AUD 7.55M for the fiscal year ended Jun 30, 2026.

    How fast is Immuron Ltd ADR's revenue growing?

    Revenue was up 3.5% for the fiscal year ended Jun 30, 2026 compared with the year before. The compound annual revenue growth rate over 3 years was 61.1%.

    Is Immuron Ltd ADR profitable?

    No. Immuron Ltd ADR reported net income of AUD -3.75M for the fiscal year ended Jun 30, 2026, with a net margin of -49.8%.

    How much free cash flow does IMRN generate?

    For the fiscal year ended Jun 30, 2026, operating cash flow of AUD -3.00M minus capital expenditures of AUD 4.65K produced free cash flow of AUD -3.00M.

    How much debt does Immuron Ltd ADR have?

    The balance sheet dated Jun 30, 2026 reported cash and equivalents of AUD 9.02M.